CPI drive refractory advances

被引：0
|
作者：
Brosnan, DA [1 ]
Crowley, MS
Johnson, RC
机构：
[1] Clemson Univ, Clemson, SC 29631 USA
[2] RCJ Global Inc, Dansville, NY 14437 USA
[3] Ctr Engn Ceram Mfg, Anderson, SC 29625 USA
来源：
CHEMICAL ENGINEERING | 1998年 / 105卷 / 11期
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：110 / +
页数：8
相关论文
共 50 条
  • [41] Advances in the treatment of hormone refractory prostate cancer
    Petrylak, Daniel P.
    CANCER INVESTIGATION, 2007, 25 : 19 - 19
  • [42] New Advances in the Management of Refractory Angina Pectoris
    Cheng, Kevin
    de Silva, Ranil
    EUROPEAN CARDIOLOGY REVIEW, 2018, 13 (01) : 70 - 79
  • [43] Refractory metal alloy advances highlighted in Annapolis
    Brookes, K.J.A.
    Metal Powder Report, 2001, 56 (05) : 26 - 28
  • [44] Advances in treatment for relapses and refractory multiple myeloma
    Richards, Tiffany
    Weber, Donna
    MEDICAL ONCOLOGY, 2010, 27 : 25 - 42
  • [45] Therapeutic Advances in Relapsed or Refractory Multiple Myeloma
    Anderson, Kenneth C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (5.5): : 676 - 679
  • [46] Refractory gastroesophageal reflux disease: advances and treatment
    Ates, Fehmi
    Francis, David O.
    Vaezi, Michael F.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (06) : 657 - 667
  • [47] Hormone refractory prostate cancer: Management and advances
    Sonpavde, G
    Hutson, TE
    Berry, WR
    CANCER TREATMENT REVIEWS, 2006, 32 (02) : 90 - 100
  • [48] Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma
    Yun Choi
    Catherine S. Diefenbach
    Current Oncology Reports, 2020, 22
  • [49] Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma
    Choi, Yun
    Diefenbach, Catherine S.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (01)
  • [50] Advances in the pharmacotherapeutic management of refractory peptic ulcers
    Laguna, Cristina Borao
    Lanas, Angel
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (07) : 825 - 833
12345